drugset / Trial / NCT06441162

Efficacy Of Combined Nebulized Hypertonic Saline and Chest Percussion Therapy in Acute Viral Bronchiolitis

NCT06441162

Phase 4 Terminated 75 enrolled NYU Langone Health
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will examine the efficacy of combined nebulized hypertonic saline with chest percussion therapy in patients age 0 to 24 months admitted to the general inpatient pediatrics unit with acute bronchiolitis. 3% nebulized hypertonic saline treatments combined with 3 minutes of chest percussion therapy will be administered every 6 hours of patients selected for the study.

Timeline

Start
2024-07-15
Primary completion
2025-05-15
Completion
2025-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 3 % Inhaled
Subject sodium chloride Unknown 4 ml Inhaled

Indications